Results 221 to 230 of about 57,705 (278)

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database. [PDF]

Front Pharmacol
Wu YY, Huang QL, Luo ZY, Song XY, Shi YY, Zheng JZ, Liu S.   +6 more
europepmc   +1 more source

Direct Effects, Compensation, and Recovery in Female Fathead Minnows Exposed to a Model Aromatase Inhibitor

, 2008
Daniel L. Villeneuve, Nathaniel D. Mueller, Dalma Martinović‐Weigelt, Elizabeth A. Makynen, Michael D. Kahl, Kathleen Jensen, Elizabeth J. Durhan, Jenna E. Cavallin, David C. Bencic, Gerald T. Ankley   +9 more
openalex   +1 more source

Pain sensation and emotion induced by aromatase inhibitors: a new mouse model. [PDF]

Pain
Li H, Han L, Li P, Lu D, Feng Y.
europepmc   +1 more source

Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score–matched cohort study

, 2017
Namki Hong, Han Gyul Yoon, Da Hea Seo, Seho Park, Seung Il Kim, Joohyuk Sohn, Yumie Rhee   +6 more
openalex   +2 more sources

Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy. [PDF]

Breast
Shai A, Wildiers H, Venieri C, Pogoda K, Linderholm B, Lambertini M, Matos L, De Maio D'Esposito E, Hajjaji N, Matos E, González Cortijo L, Fotia G, Fortuna A, Sella T, Gouveia H, Rosset L, Constantinidou A, Angeli E, Cicin I, Tjan-Heijnen V, Ruyssers N, Demasure S, Abu Remilah A, Huygh G, Paluch-Shimon S, Chiappe E, Shirron N, Neven P, Artac M, Kilictas B, Baranseh J, Vicente-Rubio E, Atci M, Amato O, van Duijnhoven F.   +34 more
europepmc   +1 more source

P221: Exploring the Role of CDK- 4/6 Inhibitors and Aromatase Inhibitors as Neoadjuvant Therapy in Breast Cancer: Response Rates in Early and Advanced Diseases of Breast Cancer

D.S. SP, D.N. Semitha, Duszynski Kr, Deepak Kumar, Datta Patil, Vivek Duraivelu, Deepti Joshi   +6 more
openalex   +1 more source

Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors. [PDF]

Cancers (Basel)
Khanyile R, Chipiti T, Hull R, Dlamini Z.   +3 more
europepmc   +1 more source

Effectiveness of supervised vs brief counselling physical activity promotion interventions in breast cancer survivors on aromatase inhibitors: the PAC-WOMAN randomized controlled trial. [PDF]

Int J Behav Nutr Phys Act
Carraça EV, Rodrigues B, Franco S, Nobre I, Jerónimo F, Ilharco V, Silva PF, Palmeira AL, Silva MN.   +8 more
europepmc   +1 more source